Disc chondrocyte transplantation in a canine model: a treatment for degenerated or damaged intervertebral disc
- PMID: 14652478
- DOI: 10.1097/01.BRS.0000097891.63063.78
Disc chondrocyte transplantation in a canine model: a treatment for degenerated or damaged intervertebral disc
Abstract
Study design: Disc degeneration and osteoarthritis are diseases of the matrix. Chondrocytes that have been removed from damaged cartilaginous tissues maintain a capacity to proliferate, produce, and secrete matrix components, and respond to physical stimuli such as dynamic loading. A dog model was used to investigate the hypothesis that autologous disc chondrocytes can be used to repair damaged intervertebral disc.
Objectives: Given the capacity for the cells in vitro to produce matrix molecules that would be appropriate for disc chondrocytes, the focus of the experiment was to investigate whether the cells would continue to sustain metabolic function after transplantation.
Summary of the background data: No evidence for long-term integration exists for cell transplantation in species other than rats and rabbits. Furthermore, no controlled studies of 1-year duration have been published.
Materials and methods: Disc chondrocytes were harvested and expanded in culture under controlled and defined conditions, returned to the same animals from which they had been sampled (autologous transplantation) via percutaneous delivery. The animals were analyzed at specific times after transplantation by several methods to examine whether disc chondrocytes integrated with the surrounding tissue, produced the appropriate intervertebral disc extracellular matrix, and might provide a formative solution to disc repair.
Results: In the context of degenerative changes in an injury model: (1) autologous disc chondrocytes were expanded in culture and returned to the disc by a minimally invasive procedure after 12 weeks; (2) disc chondrocytes remained viable after transplantation as shown by Bromodeoxyuridine incorporation and maintained a capacity for proliferation after transplantation as depicted by histology; (3) transplanted disc chondrocytes produced an extracellular matrix that displayed composition similar to normal intervertebral disc tissue. Positive evidence of proteoglycan content was supported by accepted histochemical staining techniques such as Safranin O-Fast Green; (4) both type II and type I collagens were demonstrated in the regenerated intervertebral disc matrix by immunohistochemistry after chondrocyte transplantation; and (5) when the disc heights were analyzed for variance according to treatment, a statistically significantcorrelation between transplanting cells and retention of disc height was achieved.
Conclusions: Autologous chondrocyte transplantation is technically feasible and biologically relevant to repairing disc damage and retarding disc degeneration.
Similar articles
-
Clinical experience in cell-based therapeutics: disc chondrocyte transplantation A treatment for degenerated or damaged intervertebral disc.Biomol Eng. 2007 Feb;24(1):5-21. doi: 10.1016/j.bioeng.2006.07.002. Epub 2006 Jul 21. Biomol Eng. 2007. PMID: 16963315
-
Cell transplantation in lumbar spine disc degeneration disease.Eur Spine J. 2008 Dec;17 Suppl 4(Suppl 4):492-503. doi: 10.1007/s00586-008-0750-6. Epub 2008 Nov 13. Eur Spine J. 2008. PMID: 19005697 Free PMC article. Review.
-
Regenerative effects of transplanting mesenchymal stem cells embedded in atelocollagen to the degenerated intervertebral disc.Biomaterials. 2006 Jan;27(3):335-45. doi: 10.1016/j.biomaterials.2005.06.038. Epub 2005 Aug 19. Biomaterials. 2006. PMID: 16112726
-
Olfactory stem cells can be induced to express chondrogenic phenotype in a rat intervertebral disc injury model.Spine J. 2009 Jul;9(7):585-94. doi: 10.1016/j.spinee.2009.02.011. Epub 2009 Apr 5. Spine J. 2009. PMID: 19345615
-
Diversity of intervertebral disc cells: phenotype and function.J Anat. 2012 Dec;221(6):480-96. doi: 10.1111/j.1469-7580.2012.01521.x. Epub 2012 Jun 11. J Anat. 2012. PMID: 22686699 Free PMC article. Review.
Cited by 67 articles
-
Clinical Development of Regenerative Medicine Targeted for Intervertebral Disc Disease.Medicina (Kaunas). 2022 Feb 10;58(2):267. doi: 10.3390/medicina58020267. Medicina (Kaunas). 2022. PMID: 35208590 Free PMC article. Review.
-
Biomaterials and Cell-Based Regenerative Therapies for Intervertebral Disc Degeneration with a Focus on Biological and Biomechanical Functional Repair: Targeting Treatments for Disc Herniation.Cells. 2022 Feb 9;11(4):602. doi: 10.3390/cells11040602. Cells. 2022. PMID: 35203253 Free PMC article. Review.
-
Cell sources proposed for nucleus pulposus regeneration.JOR Spine. 2021 Nov 24;4(4):e1175. doi: 10.1002/jsp2.1175. eCollection 2021 Dec. JOR Spine. 2021. PMID: 35005441 Free PMC article. Review.
-
Holistic Approach of Swiss Fetal Progenitor Cell Banking: Optimizing Safe and Sustainable Substrates for Regenerative Medicine and Biotechnology.Front Bioeng Biotechnol. 2020 Oct 23;8:557758. doi: 10.3389/fbioe.2020.557758. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 33195124 Free PMC article.
-
Intervertebral Disc Repair: Current Concepts.Global Spine J. 2020 Apr;10(2 Suppl):130S-136S. doi: 10.1177/2192568219872460. Epub 2020 May 28. Global Spine J. 2020. PMID: 32528797 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials